Cronos Group Inc

NASDAQ: CRON
$2.22
+$0.02 (+0.9%)
Closing Price on November 5, 2024

CRON Stock Chart and Intraday Price

CRON Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Address 111 PETER STREET, SUITE 300, TORONTO, ON, CA
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 773.97M USD
Shares Outstanding 381,114,000
Cronos Group Inc. is a leading cannabinoid company based in Toronto, Canada, known for its innovative approach to cannabis and hemp-derived products. Since its founding in 2012, Cronos has made a mark by manufacturing, marketing, and distributing a diverse range of products, including supplements and cosmetics under the Lord Jones brand, primarily in the United States. The company also focuses on the cultivation and sale of cannabis for both medical and recreational use, offering products like dried cannabis, edibles, and concentrates under its PEACE NATURALS and Spinach brands.

CRON Articles

The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi...
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.
Here is what analysts expect to hear when these five firms report quarterly results Monday and Tuesday.
Tuesday's additional top analyst upgrades and downgrades included Canopy Growth, ContextLogic, Cronos, Ecolab, Keurig Dr Pepper, LyondellBasell Industries, Procter & Gamble, Phillip Morris...
Thursday afternoon's top analyst upgrades and downgrades included Equifax, Corning, Iridium Communications, KB Home and Tesla.
Nearly every electric vehicle stock traded lower Thursday, as investors likely were pocketing some profits on the recent runup in these stocks.
Thursday afternoon's analyst upgrades and downgrades included Activision Blizzard, Boeing, Canopy Growth, GoPro, PayPal, Roblox, Visa and more.
Meme stocks, like Monday's broad markets, were trading higher, with more winners than losers and more new highs than new lows.
Pot grower Tilray is acquiring a majority position in U.S.-based cannabis retailer MedMen. Is this a portent of more consolidation in the industry?
Wednesday's announcement of a draft bill that would decriminalize marijuana sent cannabis stocks plummeting. At least some analysts, however, continue to believe in the sector.
Analysts at BofA Securities on Wednesday resumed coverage of four top marijuana producers and rated two of them at Buy.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Canopy Growth, Cimarex Energy, Credit Suisse, Fastly, Lemonade, Mattel, Ralph Lauren and ViacomCBS.
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
The New York state legislature has approved a bill legalizing marijuana in the state and the governor has said he will sign it. Pot stocks are high on the news.